Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022363

Expand all

LIVALO (PITAVASTATIN CALCIUM)
EQ 1MG BASE Marketing Status: Prescription

Active Ingredient: PITAVASTATIN CALCIUM
Proprietary Name: LIVALO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022363
Product Number: 001
Approval Date: Aug 3, 2009
Applicant Holder Full Name: KOWA CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

LIVALO (PITAVASTATIN CALCIUM)
EQ 2MG BASE Marketing Status: Prescription

Active Ingredient: PITAVASTATIN CALCIUM
Proprietary Name: LIVALO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022363
Product Number: 002
Approval Date: Aug 3, 2009
Applicant Holder Full Name: KOWA CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

LIVALO (PITAVASTATIN CALCIUM)
EQ 4MG BASE Marketing Status: Prescription

Active Ingredient: PITAVASTATIN CALCIUM
Proprietary Name: LIVALO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 4MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022363
Product Number: 003
Approval Date: Aug 3, 2009
Applicant Holder Full Name: KOWA CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English